Published in Sci Rep on May 25, 2016
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc (2012) 35.75
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res (2004) 14.73
A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A (2004) 6.84
Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst (1999) 3.25
Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res (2008) 3.22
Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs (2009) 2.90
Rapid, label-free detection of brain tumors with stimulated Raman scattering microscopy. Sci Transl Med (2013) 2.31
Intraoperative brain cancer detection with Raman spectroscopy in humans. Sci Transl Med (2015) 1.89
Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol (2002) 1.74
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts. Neuro Oncol (2008) 1.57
The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner. Cancer Res (2002) 1.57
Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene (2004) 1.54
A role for ceramide in driving cancer cell resistance to doxorubicin. FASEB J (2008) 1.44
Raman spectroscopy for identification of epithelial cancers. Faraday Discuss (2004) 1.36
Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma. Br J Cancer (2006) 1.29
Quantitative physiology of the precancerous cervix in vivo through optical spectroscopy. Neoplasia (2009) 1.28
The use of Raman spectroscopy to differentiate between different prostatic adenocarcinoma cell lines. Br J Cancer (2005) 1.18
Multidrug resistance: Physiological principles and nanomedical solutions. Adv Drug Deliv Rev (2013) 1.15
Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance. Adv Cancer Res (2013) 0.99
Glioblastoma multiforme: a look inside its heterogeneous nature. Cancers (Basel) (2014) 0.99
Ex vivo and in vivo diagnosis of C6 glioblastoma development by Raman spectroscopy coupled to a microprobe. Anal Bioanal Chem (2010) 0.98
Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition. Mol Cancer (2013) 0.96
Comparative evaluation of spectroscopic models using different multivariate statistical tools in a multicancer scenario. J Biomed Opt (2011) 0.95
Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines. J Neurooncol (2011) 0.94
Discriminating vital tumor from necrotic tissue in human glioblastoma tissue samples by Raman spectroscopy. Lab Invest (2002) 0.94
Prognostic factors for long-term survival after glioblastoma. Perm J (2008) 0.94
Illuminating disease and enlightening biomedicine: Raman spectroscopy as a diagnostic tool. Analyst (2013) 0.91
Human brain cancer studied by resonance Raman spectroscopy. J Biomed Opt (2012) 0.91
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells. Exp Oncol (2012) 0.88
In vivo Raman spectroscopic identification of premalignant lesions in oral buccal mucosa. J Biomed Opt (2012) 0.88
Prediction of radiotherapy response in cervix cancer by Raman spectroscopy: a pilot study. Biopolymers (2008) 0.88
Protective properties of radio-chemoresistant glioblastoma stem cell clones are associated with metabolic adaptation to reduced glucose dependence. PLoS One (2013) 0.87
Raman spectroscopic study of radioresistant oral cancer sublines established by fractionated ionizing radiation. PLoS One (2014) 0.87
Raman spectroscopy to distinguish grey matter, necrosis, and glioblastoma multiforme in frozen tissue sections. J Neurooncol (2014) 0.85
Optical spectroscopy: current advances and future applications in cancer diagnostics and therapy. Future Oncol (2012) 0.85
Radiation-induced homotypic cell fusions of innately resistant glioblastoma cells mediate their sustained survival and recurrence. Carcinogenesis (2015) 0.84
Near-infrared FT-Raman spectra of the rat brain tissues. Neurosci Lett (1992) 0.84
Ki-67 labeling is correlated with the time to recurrence in primary glioblastomas. J Neurooncol (2002) 0.83
Recurrence prediction in oral cancers: a serum Raman spectroscopy study. Analyst (2015) 0.82
Vision 20/20: the role of Raman spectroscopy in early stage cancer detection and feasibility for application in radiation therapy response assessment. Med Phys (2014) 0.81
Serum based diagnosis of asthma using Raman spectroscopy: an early phase pilot study. PLoS One (2013) 0.80
A Raman spectroscopic study of cell response to clinical doses of ionizing radiation. Appl Spectrosc (2015) 0.80
Raman spectroscopy of blood serum for Alzheimer's disease diagnostics: specificity relative to other types of dementia. J Biophotonics (2014) 0.79
The diagnosis of lung cancer using 1064-nm excited near-infrared multichannel Raman spectroscopy. Radiat Med (2003) 0.79
Identification and characterization of colorectal cancer using Raman spectroscopy and feature selection techniques. Opt Express (2014) 0.78
Characterisation of uterine sarcoma cell lines exhibiting MDR phenotype by vibrational spectroscopy. Biochim Biophys Acta (2005) 0.78